Skip to main content
Caplight Logo









Evosep

Evosep

Private
OdenseHealthcare & Life Scienceshttps://evosep.com/

Last Round

Buyout/LBO

Nov 18, 2025

Total Funding Raised

$40M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Evosep is a biotechnology company that develops standardized sample preparation and separation solutions for clinical proteomics and mass spectrometry workflows.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Medical Devices, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

liquid chromatographyclinical proteomicsmass spectrometryhigh-throughput chromatographyproteomics workflowsample preparationbiomarker discoveryrazor-and-bladelab consumablesclinical diagnosticsLC-MSanalytical chemistrybiotech equipmentprecision medicinelab automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Evosep Comparables

Compare Evosep with similar companies based on industry and business-model similarity.

Evosep comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bruker
79%
IonOpticks
75%
Danaher
74%

Evosep Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Buyout/LBONov 18, 2025
Growth EquityJan 9, 2023

Evosep Investors

Notable investors and investment history

Evosep investors
InvestorRounds
Nordic CapitalBuyout/LBO
Novo HoldingsGrowth Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 15, 2026

    Monthly visitors grew 108% MoM, reaching 17K.

  • Apr 3, 2026

    Monthly visitors grew 58% MoM, reaching 12.9K.

Recent news

Latest coverage and updates

  • partners_withSep 29, 2026

    Evosep partnered with Mass Dynamics on Sep 29th '26.

Evosep Filings

Explore SEC and related filing metadata, where available.

Evosep filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Evosep's valuation, stock price, and market status.

Is Evosep a public or private company?

Evosep is a private company.

What is the current stock price of Evosep?

Evosep is a private company, so its shares have no public market price. Caplight tracks Evosep's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Evosep worth (valuation)?

Valuation information for Evosep is not publicly available.

Can I buy Evosep stock?

Evosep shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Evosep's last funding round?

Evosep's most recent funding round was Buyout/LBO on November 18, 2025.

Who are the main investors in Evosep?

Key investors in Evosep include Nordic Capital, Novo Holdings.

Will Evosep IPO soon?

No public IPO plans have been announced for Evosep.

How can I track Evosep secondary market activity?

Caplight tracks bids, offers, and trades in Evosep's shares on secondary markets.

Firmographic Details

HeadquartersOdense
Employee Range80
Year Founded2016
Last FundingNov 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?